Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors
dc.contributor.author | Ökten, Salih | |
dc.contributor.author | Aydın, Ali | |
dc.contributor.author | Koçyiğit, Ümit M. | |
dc.contributor.author | Çakmak, Osman | |
dc.contributor.author | Erkan, Sultan | |
dc.contributor.author | Andaç, Cenk A. | |
dc.contributor.author | Taslimi, Parham | |
dc.date.accessioned | 2021-01-14T18:10:25Z | |
dc.date.available | 2021-01-14T18:10:25Z | |
dc.date.issued | 2020 | |
dc.department | KKÜ | |
dc.description | Okten, Salih/0000-0001-9656-1803; Gulcin, ilhami/0000-0001-5993-1668; aydin, ali/0000-0002-9550-9111; Taslimi, Parham/0000-0002-3171-0633 | |
dc.description.abstract | A series of substituted quinolines was screened for their antiproliferative, cytotoxic, antibacterial activities, DNA/protein binding affinity, and anticholinergic properties by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell proliferation, lactate dehydrogenase cytotoxicity, and microdilution assays, the Wolfe-Shimmer equality method, the Ellman method, and the esterase assay, respectively. The results of the cytotoxic and anticancer activities of the compounds displayed that 6-bromotetrahydroquinoline (2), 6,8-dibromotetrahydroquinoline (3), 8-bromo-6-cyanoquinoline (10), 5-bromo-6,8-dimethoxyquinoline (12), the novelN-nitrated 6,8-dimethoxyquinoline (13), and 5,7-dibromo-8-hydroxyquinoline (17) showed a significant antiproliferative potency against the A549, HeLa, HT29, Hep3B, and MCF7 cancer cell lines (IC50 = 2-50 mu g/ml) and low cytotoxicity (similar to 7-35%) as the controls, 5-fluorouracil and cisplatin. The compound-DNA linkages are hyperchromic or hypochromic, causing variations in their spectra. This situation shows that they can be bound to DNA with the groove-binding mode, withK(b)value in the range of 2.0 x 10(3)-2.2 x 10(5) M-1. Studies on human Gram(+) and Gram(-) pathogenic bacteria showed that the substituted quinolines exhibited selective antimicrobial activities with MIC values of 62.50-250 mu g/ml. All tested quinoline derivatives were found to be effective inhibitors of acetylcholinesterase (AChE) and the human carbonic anhydrase I and II isoforms (hCA I and II), withK(i)values of 46.04-956.82 nM for hCA I, 54.95-976.93 nM for hCA II, and 5.51-155.22 nM for AChE. As a result, the preliminary data showed that substituted quinolines displayed effective pharmacological features. Molecular docking studies were performed to investigate the binding modes and interaction energies for compounds2-17with AChE (PDB ID: 4EY6), hCA I (PDB ID: 1BMZ), and hCA II (PDB ID: 2ABE). | en_US |
dc.identifier.citation | closedAccess | en_US |
dc.identifier.doi | 10.1002/ardp.202000086 | |
dc.identifier.issn | 0365-6233 | |
dc.identifier.issn | 1521-4184 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 32537757 | |
dc.identifier.scopus | 2-s2.0-85090079624 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.uri | https://doi.org/10.1002/ardp.202000086 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/12585 | |
dc.identifier.volume | 353 | en_US |
dc.identifier.wos | WOS:000567558100004 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | WILEY-V C H VERLAG GMBH | en_US |
dc.relation.ispartof | ARCHIV DER PHARMAZIE | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | acetylcholinesterase enzyme inhibition | en_US |
dc.subject | antibacterial | en_US |
dc.subject | anticancer activity | en_US |
dc.subject | carbonic anhydrase enzyme inhibition | en_US |
dc.subject | DNA binding | en_US |
dc.subject | molecular docking | en_US |
dc.subject | quinolone | en_US |
dc.title | Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors | en_US |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
[ X ]
- İsim:
- Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors.pdf
- Boyut:
- 4.28 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text